Literature DB >> 8611180

Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors.

C Serveau1, G Lalmanach, M A Juliano, J Scharfstein, L Juliano, F Gauthier.   

Abstract

A panel of intramolecularly quenched fluorogenic substrates containing the conserved QVVA and LVG inhibitory sequences of cystatin inhibitors was used to describe the specificity of the major cysteine proteinase of Trypanosoma cruzi (cruzipain or cruzain). This approach was based on the observations that: (1) cruzipain is strongly inhibited by chicken cystatin and rat T-kininogen, two representative members of cystatin families 2 and 3; (2) the QVVA- and LVG-containing substrates are specifically hydrolysed by papain-like proteinases; and (3) the cystatin-like motifs are similar to the proteolytically sensitive sequences in cruzipain that separate the pro-region and/or the C-terminal extension from the catalytic domain. Specificity constants (kcat/Km) were determined and compared with those of mammalian cathepsins B and L from rat liver lysosomes. Cruzipain and the mammalian proteinases cleaved cystatin-derived substrates at the same site, but their specificities differed significantly. Increased specificity for cruzipain was obtained by replacing amino acids at critical positions on both sides of the cleavage sites, especially at position P2'. The specificity constants (k(cat)/Km) obtained for the two substrates with a prolyl residue at P2' (O-aminobenzoyl-QVVAGP-ethylenediamine 2-4-dinitrophenyl and O-aminobenzoyl-VVGGP-ethylenediamine 2-4-dinitrophenyl) were about 50 times higher for cruzipain than for rat cathepsin L and about 100 times higher than for cathepsin B. Diazomethylketone derivatives, based on the non-prime sequence of cystatin-derived substrates, inhibited cruzipain irreversibly, but their inactivation rate constants were considerably lower than those for mammalian cathepsins B and L, confirming the importance of P' residues for cruzipain specificity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611180      PMCID: PMC1217003          DOI: 10.1042/bj3130951

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Cysteine proteinases of parasitic protozoa.

Authors:  M J North; J C Mottram; G H Coombs
Journal:  Parasitol Today       Date:  1990-08

2.  A model to explain the pH-dependent specificity of cathepsin B-catalysed hydrolyses.

Authors:  H E Khouri; C Plouffe; S Hasnain; T Hirama; A C Storer; R Ménard
Journal:  Biochem J       Date:  1991-05-01       Impact factor: 3.857

3.  Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes.

Authors:  I Björk; E Pol; E Raub-Segall; M Abrahamson; A D Rowan; J S Mort
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

4.  Identification of new cysteine protease gene isoforms in Trypanosoma cruzi.

Authors:  A P Lima; D C Tessier; D Y Thomas; J Scharfstein; A C Storer; T Vernet
Journal:  Mol Biochem Parasitol       Date:  1994-10       Impact factor: 1.759

5.  Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.

Authors:  G Lalmanach; C Serveau; M Brillard-Bourdet; J R Chagas; R Mayer; L Juliano; F Gauthier
Journal:  J Protein Chem       Date:  1995-11

6.  Cysteine-proteinase-inhibiting function of T kininogen and of its proteolytic fragments.

Authors:  T Moreau; F Esnard; N Gutman; P Degand; F Gauthier
Journal:  Eur J Biochem       Date:  1988-04-05

7.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

8.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

9.  Further characterization and partial amino acid sequence of a cysteine proteinase from Trypanosoma cruzi.

Authors:  J J Cazzulo; R Couso; A Raimondi; C Wernstedt; U Hellman
Journal:  Mol Biochem Parasitol       Date:  1989-02       Impact factor: 1.759

10.  Cysteine proteinase in Trypanosoma cruzi: immunocytochemical localization and involvement in parasite-host cell interaction.

Authors:  T Souto-Padrón; O E Campetella; J J Cazzulo; W de Souza
Journal:  J Cell Sci       Date:  1990-07       Impact factor: 5.285

View more
  9 in total

1.  Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides.

Authors:  E D Nery; M A Juliano; M Meldal; I Svendsen; J Scharfstein; A Walmsley; L Juliano
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

2.  Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.

Authors:  F C Portaro; A B Santos; M H Cezari; M A Juliano; L Juliano; E Carmona
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.

Authors:  G Lalmanach; R Mayer; C Serveau; J Scharfstein; F Gauthier
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin.

Authors:  Florian Veillard; Ahlame Saidi; Roberta E Burden; Christopher J Scott; Ludovic Gillet; Fabien Lecaille; Gilles Lalmanach
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

5.  Probing cathepsin K activity with a selective substrate spanning its active site.

Authors:  Fabien Lecaille; Enrico Weidauer; Maria A Juliano; Dieter Brömme; Gilles Lalmanach
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

6.  In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.

Authors:  Yen Ting Chen; Linda S Brinen; Iain D Kerr; Elizabeth Hansell; Patricia S Doyle; James H McKerrow; William R Roush
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

7.  Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.

Authors:  Bhaskar R Shenai; Belinda J Lee; Alejandro Alvarez-Hernandez; Pek Y Chong; Cory D Emal; R Jeffrey Neitz; William R Roush; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

8.  Characterization of a novel cysteine protease inhibitor in Baylisascaris schroederi migratory larvae and its role in regulating mice immune cell response.

Authors:  Jingyun Xu; Xiaobin Gu; Yue Xie; Ran He; Jing Xu; Lang Xiong; Xuerong Peng; Guangyou Yang
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

9.  A novel cysteine protease inhibitor in Baylisascaris schroederi migratory larvae regulates inflammasome activation through the TLR4-ROS-NLRP3 pathway.

Authors:  Jingyun Xu; Xiaobin Gu; Yue Xie; Ran He; Jing Xu; Lang Xiong; Xuerong Peng; Guangyou Yang
Journal:  Parasit Vectors       Date:  2022-09-23       Impact factor: 4.047

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.